missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. SLC44A2 Rabbit anti-Human, Polyclonal, Novus Biologicals™
  7. 18386915

SLC44A2 Rabbit anti-Human, Polyclonal, Novus Biologicals™

Rabbit Polyclonal Antibody

Brand:  Novus Biologicals NBP3-10576-100UL

 View more versions of this product

Product Code. 18386915

  • £359.00 / 100µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

SLC44A2 Polyclonal specifically detects SLC44A2 in Human samples. It is validated for Western Blot, Immunohistochemistry.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

SLC44A2
Polyclonal
Western Blot 1.0 ug/ml, Immunohistochemistry
CTL2choline transporter-like protein 2, DKFZp666A071, FLJ44586, PP1292, Solute carrier family 44 member 2, solute carrier family 44, member 2
The immunogen is a synthetic peptide directed towards the middle region of Human SLC44A2 (NP_065161). Peptide sequence IMVWVMIIMVILVLGYGIFHCYMEYSRLRGEAGSDVSLVDLGFQTDFRVY
100 μg
Signal Transduction
57153
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Western Blot, Immunohistochemistry
Unconjugated
PBS buffer, 2% sucrose
Rabbit
Affinity purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.